Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
20,324 results
- Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Extended Bolus for Meals in a Closed-loop System: Complete Statistical AnalysisIndependent statistical analysis of Extended Bolus for Meals in a Closed-loop System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05454891).
- Extended Dosing With Eltrombopag for Severe Aplastic Anemia: Complete Statistical AnalysisIndependent statistical analysis of Extended Dosing With Eltrombopag for Severe Aplastic Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01891994).
- Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation: Complete Statistical AnalysisIndependent statistical analysis of Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02720536).
- Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069): Complete Statistical AnalysisIndependent statistical analysis of Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00485758).
- Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children: Complete Statistical AnalysisIndependent statistical analysis of Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users: Complete Statistical AnalysisIndependent statistical analysis of Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail: Complete Statistical AnalysisIndependent statistical analysis of Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01180647).
- Extending taVNS Paired With Infant CIMT Into a Home-Based Setting: Complete Statistical AnalysisIndependent statistical analysis of Extending taVNS Paired With Infant CIMT Into a Home-Based Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05857527).
- Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898): Complete Statistical AnalysisIndependent statistical analysis of Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Extension Study of Ataluren (PTC124) in Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of Ataluren (PTC124) in Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01140451).
- Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Extension Study of IMO-8400 in Patients With Waldenström’s Macroglobulinemia Who Completed Study 8400-401: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Extension Study of MYL-1701P-3001 for Safety and Efficacy: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of MYL-1701P-3001 for Safety and Efficacy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04674800).
- Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome): Complete Statistical AnalysisIndependent statistical analysis of Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03121586).
- Extension Study of PRX-102 for up to 60 Months: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of PRX-102 for up to 60 Months: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01981720).
- Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID): Complete Statistical AnalysisIndependent statistical analysis of Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study: primary endpoint results, effect estimate with confidence interval, sample-size…
- Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection: primary endpoint results, effect estimate with confidence interval, sample-size…
- Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia: Complete Statistical AnalysisIndependent statistical analysis of Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU): Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU): primary endpoint results, effect estimate with confidence interval, sample-size…
- Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.: Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects.: primary endpoint results, effect estimate with confidence interval,…
- Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3): Complete Statistical AnalysisIndependent statistical analysis of Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3): primary endpoint…
- Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.: Complete Statistical AnalysisIndependent statistical analysis of Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects: Complete Statistical AnalysisIndependent statistical analysis of Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects: primary endpoint results, effect estimate…
- Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size…
- Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038): Complete Statistical AnalysisIndependent statistical analysis of Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- External Fixation Versus Splinting of Acute Calcaneus Fractures: Complete Statistical AnalysisIndependent statistical analysis of External Fixation Versus Splinting of Acute Calcaneus Fractures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04063657).
- External Trigeminal Nerve Stimulation for Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of External Trigeminal Nerve Stimulation for Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01159431).
- eXtRaIndependent statistical analysis of Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia: primary endpoint results, effect estimate with confidence interval,…
- EXTRAIndependent statistical analysis of A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA): primary endpoint results,…
- EXTRA-CVDIndependent statistical analysis of A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Extracorporeal Membrane Oxygenation (ECMO) in Non-intubated Patients With Acute Respiratory Distress Syndrome (ARDS): Complete Statistical AnalysisIndependent statistical analysis of Extracorporeal Membrane Oxygenation (ECMO) in Non-intubated Patients With Acute Respiratory Distress Syndrome (ARDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD): Complete Statistical AnalysisIndependent statistical analysis of Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Eye MovementIndependent statistical analysis of The Effect of Sedation on Eye Movements: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00646646).
- Eye Tracking as a Biomarker of Cannabis Effects: Complete Statistical AnalysisIndependent statistical analysis of Eye Tracking as a Biomarker of Cannabis Effects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04100590).
- EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery: Complete Statistical AnalysisIndependent statistical analysis of EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…